Table 1 GST allelic variants associated with cancer risk and other diseases

From: Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases

Gene

Allelic variant

Modification

OMIM number

Diseases

Ref.

GSTM1

GSTM1*O

Gene deletion

138350

Uterine leiomyoma, hypertension, oral leukoplakia, prostate cancer, chronic myeloid leukemia, breast cancer, epilepsy

35,36,37, 39,40,41, 61

GSTT1

GSTT1*O

Gene deletion

600436

Uterine leiomyoma, hypertension, oral leukoplakia, brain tumour, breast cancer, coronary heart disease, psoriasisa, epilepsy

35,36,37,38, 40,43, 44

GSTP1

GSTP1*B

Ile105Val

134660.0002

chronic myeloid leukemia, Parkinson’s disease, Amyotrophic lateral sclerosis

39,56, 66

 

GSTP1*C

Ile105Val/Ala114Val

134660.0003

Alzheimer’s disease, Parkinson’s disease

52, 56

 

GSTP1*D

Ala114Val

Brain tumour, Parkinson’s disease

38, 56

GSTA1

GSTA1*B

-69(C/T), mutation promoter

138359

Psoriasisb

44

GSTO1

GSTO1*B

Glu155 deletion

605482

Alzheimer’s disease

53

GSTO2

GSTO2*B c

Asn142Asp

612314

Breast cancer

42

 

GSTO2*C c

Ala183Gly

Spinocerebellar ataxia type 2

65

  1. OMIM Online Mendelian Inheritance in Man
  2. a in association with GSTA1*A
  3. b in association with GSTT1*A
  4. c Allelic variants were identified as B and C in this work following the nomenclature by Townsend and Tew34